EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

Tarsus Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security
Type

Security Class Title

Fee

Calculation

or Carry
Forward

Rule

Amount

Registered

Proposed

Maximum

Offering

Price

Per Unit

Maximum

Aggregate

Offering

Price(1)

Fee Rate

Amount of

Registration

Fee(1)

Newly Registered Securities

Fees to

Be Paid

Equity

Common Stock,

$0.0001 par value per share

Rule 457(r)

3,230,336(2)

$44.50

$143,749,952.00

0.00015310

$22,008.12

Fees

Previously

Paid

N/A

Carry Forward Securities

Carry

Forward

Securities

N/A

Total Offering Amounts

$143,749,952.00

$22,008.12

Total Fees Previously Paid

—

Total Fee Offsets

$—

Net Fee Due

$22,008.12

(1)	In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, or the Securities Act, the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 (Registration No. 333-277523), which was filed on February 29, 2024.

(2)	Includes 421,348 of common stock that the underwriters have an option to purchase.